These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 17163842

  • 1. Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours?
    Liegl B, Leithner A, Bauernhofer T, Windhager R, Guelly C, Regauer S, Beham A.
    Histopathology; 2006 Dec; 49(6):576-81. PubMed ID: 17163842
    [Abstract] [Full Text] [Related]

  • 2. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
    Wilczynski SP, Chen YY, Chen W, Howell SB, Shively JE, Alberts DS.
    Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
    [Abstract] [Full Text] [Related]

  • 3. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
    Basciani S, Brama M, Mariani S, De Luca G, Arizzi M, Vesci L, Pisano C, Dolci S, Spera G, Gnessi L.
    Cancer Res; 2005 Mar 01; 65(5):1897-903. PubMed ID: 15753388
    [Abstract] [Full Text] [Related]

  • 4. Response of extraabdominal desmoid tumors to therapy with imatinib mesylate.
    Mace J, Sybil Biermann J, Sondak V, McGinn C, Hayes C, Thomas D, Baker L.
    Cancer; 2002 Dec 01; 95(11):2373-9. PubMed ID: 12436445
    [Abstract] [Full Text] [Related]

  • 5. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I, Araujo ES, Kalil RK, Bacchini P, Bertoni F, Unni KK, Park YK.
    Pathol Res Pract; 2007 Dec 01; 203(3):127-34. PubMed ID: 17298867
    [Abstract] [Full Text] [Related]

  • 6. Expression of platelet-derived growth factor receptor in low-grade endometrial stromal sarcomas in the absence of activating mutations.
    Liegl B, Gülly C, Reich O, Nogales FF, Beham A, Regauer S.
    Histopathology; 2007 Mar 01; 50(4):448-52. PubMed ID: 17448020
    [Abstract] [Full Text] [Related]

  • 7. The role of imatinib mesylate in adjuvant therapy of extra-abdominal desmoid tumors.
    Ioannou M, Demertzis N, Iakovidou I, Kottakis S.
    Anticancer Res; 2007 Mar 01; 27(2):1143-7. PubMed ID: 17465254
    [Abstract] [Full Text] [Related]

  • 8. Expression of tyrosine kinase receptors in malignant midgut carcinoid tumors.
    Welin S, Fjällskog ML, Saras J, Eriksson B, Janson ET.
    Neuroendocrinology; 2006 Mar 01; 84(1):42-8. PubMed ID: 17047316
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical and molecular cytogenetic evaluation of potential targets for tyrosine kinase inhibitors in Langerhans cell histiocytosis.
    Caponetti GC, Miranda RN, Althof PA, Dobesh RC, Sanger WG, Medeiros LJ, Greiner TC, Weisenburger DD.
    Hum Pathol; 2012 Dec 01; 43(12):2223-8. PubMed ID: 22748304
    [Abstract] [Full Text] [Related]

  • 10. Expression of platelet-derived growth factor (PDGF) in the epididymis and analysis of the epididymal development in PDGF-A, PDGF-B, and PDGF receptor beta deficient mice.
    Basciani S, Mariani S, Arizzi M, Brama M, Ricci A, Betsholtz C, Bondjers C, Ricci G, Catizone A, Galdieri M, Spera G, Gnessi L.
    Biol Reprod; 2004 Jan 01; 70(1):168-77. PubMed ID: 14522834
    [Abstract] [Full Text] [Related]

  • 11. Expression of imatinib mesylate-targeted kinases in endometrial carcinoma.
    Slomovitz BM, Broaddus RR, Schmandt R, Wu W, Oh JC, Ramondetta LM, Burke TW, Gershenson DM, Lu KH.
    Gynecol Oncol; 2004 Oct 01; 95(1):32-6. PubMed ID: 15385107
    [Abstract] [Full Text] [Related]

  • 12. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y, Haginoya K, Sun G, Dai H, Onuma A, Iinuma K.
    J Pathol; 2003 Sep 01; 201(1):149-59. PubMed ID: 12950028
    [Abstract] [Full Text] [Related]

  • 13. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
    Rocconi RP, Matthews KS, Kimball KJ, Conner MG, Baker AC, Barnes MN.
    Reprod Sci; 2008 Sep 01; 15(7):673-7. PubMed ID: 18492696
    [Abstract] [Full Text] [Related]

  • 14. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract.
    Rossi G, Valli R, Bertolini F, Marchioni A, Cavazza A, Mucciarini C, Migaldi M, Federico M, Trentini GP, Sgambato A.
    Histopathology; 2005 May 01; 46(5):522-31. PubMed ID: 15842634
    [Abstract] [Full Text] [Related]

  • 15. Analysis of protein tyrosine kinases expression in the melanoma metastases of patients treated with Imatinib Mesylate (STI571, Gleevec).
    Ivan D, Niveiro M, Diwan AH, Eton O, Kim KB, Lacey C, Gonzalez C, Prieto VG.
    J Cutan Pathol; 2006 Apr 01; 33(4):280-5. PubMed ID: 16630177
    [Abstract] [Full Text] [Related]

  • 16. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
    Zymek P, Bujak M, Chatila K, Cieslak A, Thakker G, Entman ML, Frangogiannis NG.
    J Am Coll Cardiol; 2006 Dec 05; 48(11):2315-23. PubMed ID: 17161265
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic targets in gastrointestinal stromal tumors].
    Wardelmann E, Schildhaus HU, Merkelbach-Bruse S, Büttner R.
    Verh Dtsch Ges Pathol; 2006 Dec 05; 90():73-9. PubMed ID: 17867582
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy.
    Haberler C, Gelpi E, Marosi C, Rössler K, Birner P, Budka H, Hainfellner JA.
    J Neurooncol; 2006 Jan 05; 76(2):105-9. PubMed ID: 16205964
    [Abstract] [Full Text] [Related]

  • 19. Sorafenib inhibits imatinib-resistant KIT and platelet-derived growth factor receptor beta gatekeeper mutants.
    Guida T, Anaganti S, Provitera L, Gedrich R, Sullivan E, Wilhelm SM, Santoro M, Carlomagno F.
    Clin Cancer Res; 2007 Jun 01; 13(11):3363-9. PubMed ID: 17545544
    [Abstract] [Full Text] [Related]

  • 20. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
    Zheng S, Chen LR, Wang HJ, Chen SZ.
    Hepatogastroenterology; 2007 Dec 01; 54(80):2285-90. PubMed ID: 18265649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.